Table 3.
Characteristics | Adjusted HR |
95% CI | p | |
---|---|---|---|---|
Risk factors | ||||
Age (year) | 0.98 | 0.95 - 1.01 | .163 | |
Gender | Male | 1.00 | ||
Female | 0.79 | 0.39 - 1.59 | .504 | |
Body mass index (kg/m2) | 0.97 | 0.93 - 1.02 | .277 | |
NYHA functional class | I | 1.00 | ||
II | 0.96 | 0.32 - 2.86 | .946 | |
III | 0.66 | 0.22 - 2.02 | .468 | |
IV | 0.62 | 0.16 - 2.36 | .481 | |
Heart failure etiology | Non-IHD | 1.00 | ||
IHD | 2.02 | 0.98 - 4.16 | .058 | |
Left ventricular ejection fraction (%) | 0.99 | 0.97 - 1.02 | .505 | |
Total comorbidity | 1.03 | 0.87 - 1.22 | .766 | |
| ||||
Independent predictors | ||||
NT-pro BNP | ≤ 581 pg/ml | 1.00 | ||
> 581 pg/ml | 2.02 | 1.08 - 3.78 | .027 | |
Depressive symptoms (total PHQ-9 score) |
No depressive symptoms (0 - 9) | 1.00 | ||
Depressive symptoms (10 - 27) | 2.70 | 1.35 - 5.39 | .005 |
CI; confidence interval, IHD; ischemic heart disease, HR; hazard ratio, NYHA; New York Heart Association, NT-pro BNP; N-terminal pro B-type natriuretic peptide, PHQ-9; the Patient Health Questionnaire 9